{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "exchange": "FRA", "shortName": "INDEX PHARM. AB AK B O.N.", "longName": "InDex Pharmaceuticals Holding AB (publ)", "messageBoardId": "finmb_384054549", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -1.5872989, "regularMarketPrice": 0.0248, "marketCap": 18481258, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1596434400000, "priceHint": 4, "regularMarketChange": -0.00039999932, "regularMarketTime": 1683892037, "regularMarketDayHigh": 0.0248, "regularMarketDayRange": "0.0246 - 0.0248", "regularMarketDayLow": 0.0246, "regularMarketVolume": 2900, "regularMarketPreviousClose": 0.0252, "bid": 0.0254, "ask": 0.046, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.0246, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.017, "fiftyTwoWeekLowChangePercent": 2.1794875, "fiftyTwoWeekRange": "0.0078 - 0.104", "fiftyTwoWeekHighChange": -0.0792, "fiftyTwoWeekHighChangePercent": -0.76153845, "fiftyTwoWeekLow": 0.0078, "fiftyTwoWeekHigh": 0.104, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.02, "sharesOutstanding": 532688000, "fiftyDayAverage": 0.02028, "fiftyDayAverageChange": 0.004520001, "fiftyDayAverageChangePercent": 0.22287974, "twoHundredDayAverage": 0.054096, "twoHundredDayAverageChange": -0.029295998, "twoHundredDayAverageChangePercent": -0.5415557, "symbol": "1NP.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Berzelius v\u00e4g 13", "city": "Solna", "zip": "171 65", "country": "Sweden", "phone": "46 8 12 20 38 50", "website": "https://www.indexpharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "InDex Pharmaceuticals Holding AB (publ), a pharmaceutical development company, develops pharmaceutical products for patients with ulcerative colitis. The company's lead drug candidate is Cobitolimod, which is in phase III clinical development for the treatment of patients with moderate to severe ulcerative colitis. It also develops a portfolio of other DNA based immunomodulatory sequences for the treatment of various immunological diseases. InDex Pharmaceuticals Holding AB (publ) was founded in 2000 and is headquartered in Solna, Sweden.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Mr. Johan  Gileus", "age": 57, "title": "Deputy CEO & Chief Financial Officer", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jenny  Sundqvist", "age": 51, "title": "Chief Exec. Officer", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Charlotte  Admyre", "age": 43, "title": "Chief Scientific Officer", "yearBorn": 1979, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Margareth  Jorvid", "age": 61, "title": "Head of Regulatory Affairs", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Eva  Arlander", "age": 58, "title": "Chief Devel. Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}